The CRO market in China was $186 million in 2007, according to a recent report from PricewaterhouseCoopers. That number represented growth of 38% from the year before, an increase that was mainly driven by outsourcing from international firms rather than domestic biopharmas. In the future, a CAGR estimated at 33% for the industry will bring the total China CRO market to $791 million in 2012, comprising 2.3% of the global CRO market. We report on these and other figures describing the China CRO, CMO and clinical trial markets.  More details...